Schedule 13G ownership disclosure

KYTO BIOPHARMA INC

Security class unavailable · CUSIP: 501572101

Event date: 2014-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-14-364775
Form type
SC 13G
Filer
BRISTOL MYERS SQUIBB CO
CIK
CIK 14272
Filed
Oct 06, 2014
Reporting period
Sep 30, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub